review Open AccessTop 1% cited

Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing

Clinical Infectious Diseases · 2020 · Vol. 71(9) · pp. 2459–2468

Timothy M. Rawson✉(National Institute for Health Research)Luke Moore(Imperial College Healthcare NHS Trust)Nina Zhu(National Institute for Health Research)Nishanthy Ranganathan(Imperial College London)Keira Skolimowska(Hammersmith Hospital)Mark Gilchrist(Hammersmith Hospital)Giovanni Satta(Imperial College London)Graham Cooke(Hammersmith Hospital)Alison Holmes(Imperial College London)

View via DOI Full-text PDF

Abstract

Despite frequent prescription of broad-spectrum empirical antimicrobials in patients with coronavirus-associated respiratory infections, there is a paucity of data to support the association with respiratory bacterial/fungal coinfection. Generation of prospective evidence to support development of antimicrobial policy and appropriate stewardship interventions specific for the COVID-19 pandemic is urgently required.

Antibiotic Use and Resistance Clostridium difficile and Clostridium perfringens research Pneumonia and Respiratory InfectionsCoinfectionMedicineAntimicrobialAntimicrobial stewardshipCoronavirusIntensive care medicineMicrobiologyImmunologyCoronavirus disease 2019 (COVID-19)Antibiotics

MeSH terms

Antimicrobial StewardshipCOVID-19SARS-CoV-2COVID-19 Drug TreatmentAnti-Infective AgentsBacterial InfectionsDrug Resistance, MicrobialHumansMycosesCoinfection

Citations

1,670

FWCI

171.44

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)